Coherus BioSciences
CHRS
#8264
Rank
โ‚น10.92 B
Marketcap
โ‚น94.80
Share price
7.62%
Change (1 day)
-75.20%
Change (1 year)

Revenue for Coherus BioSciences (CHRS)

Revenue in 2024 (TTM): โ‚น25.66 B

According to Coherus BioSciences 's latest financial reports the company's current revenue (TTM) is โ‚น25.85 B. In 2023 the company made a revenue of โ‚น21.41 B an increase over the revenue in the year 2022 that were of โ‚น17.46 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Coherus BioSciences from 2014 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) โ‚น25.66 B19.84%
2023 โ‚น21.41 B22.63%
2022 โ‚น17.46 B-28.24%
2021 โ‚น24.33 B-29.95%
2020 โ‚น34.74 B37.07%
2019 โ‚น25.34 B
2018 N/A-100%
2017 โ‚น99.35 M-99.23%
2016 โ‚น12.91 B547.2%
2015 โ‚น1.99 B1.4%
2014 โ‚น1.96 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚น9.70 B-62.46%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น31.29 M-99.88%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น2.595 T 9,939.14%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น50.53 B 95.48%๐Ÿ‡บ๐Ÿ‡ธ USA